top of page
Utilizing Slyde for Pain, Anxiety,
and Addiction Cessation
Explore how Slyde's innovative formulations and delivery methods can help manage pain, alleviate anxiety, and support the cessation of harmful addictions.
Slyde's Innovative Delivery Technology
Discover how Slyde's state-of-the-art ultrasonic nebulizer and smart adapter technology revolutionize the delivery of therapeutic formulations. By utilizing water-based nanostructures and precise dosing mechanisms, Slyde ensures efficient absorption of active ingredients, providing effective relief and support in managing various health conditions.
1. Advanced Nanoparticle Delivery Systems:
At Slyde, we're pioneering the use of nanoparticle technology to revolutionize how therapeutic agents are delivered in cancer treatment. Our system reduces active pharmaceutical ingredients to the nanometer scale, enhancing their absorption and targeting capabilities.
This precise delivery method ensures that treatments are directed exactly where they're needed, maximizing efficacy while minimizing side effects. By pushing the limits of nanotechnology, we're making treatments more efficient and personalized.
Formulations for Varies Conditions Using SLYDE’s Nebulizer Adapters:
2. Innovative Smart Nebulizer Technology:
Our state-of-the-art smart nebulizers utilize ultrasonic and mesh technologies to deliver medications with unparalleled accuracy. Equipped with adaptive aerosol delivery systems, these nebulizers analyze individual breathing patterns to optimize the timing and dosage of aerosolized treatments.
This ensures that therapeutic agents are delivered efficiently to the target areas, enhancing the effectiveness of the treatment and improving patient adherence.
By integrating advanced sensors and smart algorithms, we're transforming the way inhalation therapies are administered.
3. Pain and anxiety formulations:
Formulations treat a range of health and medical conditions, primarily anxiety or panic attacks, stress, depression, bipolar disorder, and chronic pain. Active Ingredients are Delta 8 (THC) and Melatonin in the form of water-based nanostructure which will be absorbed in the oral cavity through the protein channels in the mucus membranes, using our ultrasonic adapter.
Method of use:
Nebulizer adapter with mesh size >8 micron@110KHZ. User sets up the required dosage, then presses the button on Slyde screen while inhaling through the mouthpiece. The device will vibrate twice before releasing the mist to the oral cavity.
4.1. Alleviation of Opioid Withdrawal by Delta-8-Tetrahydrocannabinol:
The United States is still in the grip of an opioid crisis! Every day, over 100 Americans die from opioid overdose, surpassing 200,000 in the last two decades alone.
Treating opioid withdrawal is challenging, often requiring adjunctive, non-opioid interventions — especially during vulnerable periods when the opioid dose is lower, such as during induction and and tapering off. Our research results provide preliminary evidence that Delta-8-Tetrahydrocannabinol may alleviate opioid withdrawal. More clinical and translational research is needed to ascertain whether the risk/benefit ratio of Delta-8-Tetrahydrocannabinol can be maximized during vulnerable periods of opioid pharmacotherapy, thereby improving quality of life and supporting recovery.
4.2. Formulations are targeted to reduce
and finally, eliminate the addiction to
harmful drugs:
Active ingredients are Psilocybin, Melatonin, and Delta 8 (THC) (alternative to THC). Our formulation will use certain hormones as the Active Pharmaceutical Ingredient Carrier.
Method of Operation:
Water soluble ingredients like Psilocybin will be delivered in micro dosages using a Slyde ultrasonic adapter. A second ultrasonic adapter will deliver Oil-soluble (Delta8) ingredients as a water-based nanosuspension.
4.3. Nicotine Addiction Secession:
Secession of nicotine addiction will be scheduled based on the individual’s current consumption. Slyde's scheduler will alter the nicotine dosage daily. Microdosing of Psylocibin will be scheduled in a similar delivery pattern.
Method of Operation:
Nicotine secession will be handled by 2 adapters: an ultrasonic nebulizer adapter and a heating element adapter. 2ml nicotine will be delivered by the Slyde smart pod adapter, scheduled to deliver nicotine based on the user's current consumption. The scheduler will slowly reduce the amount of nicotine. The second adapter is the ultrasonic nebulizer which will deliver a scheduled microdose of psilocybin.
5. Epileptic Episode Detection and Response System:
This advanced application combines wearable technology with AI-driven analysis for epileptic patients. Key features include:
-
Wearable Device: Monitors vital signs to detect early signs of an impending seizure or attempts to wake the patient if they are asleep.
-
Real-Time Data: The wearable sends data to the dashboard via an app.
-
AI Analysis: The dashboard uses AI to analyze the data and determine if a true seizure alarm exists.
-
Emergency Alerts: Alerts are sent to medical professionals, the patient, or close relatives if a seizure is detected.
-
Slyde Nebulizer Integration: The dashboard communicates pre-seizure information to the Slyde Ultrasonic Nebulizer.
-
Remote Dosage Setup: The dashboard remotely adjusts the dosage of Diazepam or nano cannabinoid based on AI analysis.
-
IoT Communication: The nebulizer is alerted and prepares the appropriate dosage for immediate intervention.
-
Diazepam: Quickly calms the brain and prevents the escalation of seizures.
-
Nano Cannabinoids: Provide targeted neuroprotective and anti-inflammatory effects to help control seizures.
-
Nano Suspension: Enhances absorption and ensures faster onset of action, making it highly effective in acute crisis situations.
6. Slyde's Research in Cancer Treatment
Explore how Slyde's innovative medical delivery systems are advancing cancer treatment. Discover how our cutting-edge technology pushes the boundaries of conventional therapy by enhancing the precision and effectiveness of drug delivery.
7. Remote Controlled Studies:
Studies will be conducted remotely by clinicians who will monitor and schedule the administration of the drugs. The user is unable to change the settings on the device. A preset scheduler will beep on Slyde when it's time to inhale - by simply inhaling through the mouthpiece.
8. Commitment to Technological Excellence:
Slyde is dedicated to continuous innovation in medical delivery systems. Our research focuses on integrating cutting-edge technologies to develop devices that are not only effective but also user-friendly.
By staying at the forefront of technological advancements, we aim to provide healthcare professionals and patients with tools that offer greater control, precision, and convenience in cancer treatment.
bottom of page